Nichole Reisdorph
Concepts (642)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metabolomics | 26 | 2025 | 679 | 4.650 |
Why?
| | Mass Spectrometry | 23 | 2025 | 741 | 2.300 |
Why?
| | Metabolome | 12 | 2023 | 350 | 2.120 |
Why?
| | Tandem Mass Spectrometry | 10 | 2023 | 533 | 1.860 |
Why?
| | Bronchoalveolar Lavage Fluid | 9 | 2024 | 654 | 1.400 |
Why?
| | Ion Mobility Spectrometry | 3 | 2020 | 5 | 1.370 |
Why?
| | Proteomics | 12 | 2019 | 1113 | 1.300 |
Why?
| | Proteome | 8 | 2019 | 474 | 1.200 |
Why?
| | Chromatography, High Pressure Liquid | 11 | 2025 | 595 | 1.180 |
Why?
| | Asthma | 12 | 2024 | 2290 | 1.160 |
Why?
| | Lipids | 6 | 2022 | 664 | 1.140 |
Why?
| | Ozone | 6 | 2025 | 131 | 1.060 |
Why?
| | Diet, Mediterranean | 2 | 2024 | 30 | 1.040 |
Why?
| | Phytochemicals | 1 | 2025 | 13 | 0.930 |
Why?
| | Tea | 1 | 2025 | 21 | 0.930 |
Why?
| | Research | 2 | 2018 | 446 | 0.890 |
Why?
| | Chromatography, Liquid | 11 | 2025 | 433 | 0.860 |
Why?
| | Amino Acids | 4 | 2020 | 503 | 0.850 |
Why?
| | Biomarkers | 25 | 2024 | 4172 | 0.850 |
Why?
| | Lung | 14 | 2025 | 4066 | 0.830 |
Why?
| | Eicosanoids | 4 | 2022 | 62 | 0.770 |
Why?
| | Blood Chemical Analysis | 3 | 2014 | 98 | 0.760 |
Why?
| | Metabolic Networks and Pathways | 5 | 2021 | 182 | 0.740 |
Why?
| | Benz(a)Anthracenes | 1 | 2021 | 2 | 0.720 |
Why?
| | Benzopyrenes | 1 | 2021 | 4 | 0.720 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 7 | 2022 | 1042 | 0.710 |
Why?
| | Animals | 60 | 2025 | 37011 | 0.700 |
Why?
| | Polycyclic Aromatic Hydrocarbons | 1 | 2021 | 29 | 0.700 |
Why?
| | Mice | 42 | 2025 | 17843 | 0.690 |
Why?
| | Pneumonia | 5 | 2025 | 638 | 0.680 |
Why?
| | Liquid-Liquid Extraction | 3 | 2018 | 14 | 0.670 |
Why?
| | Docosahexaenoic Acids | 5 | 2025 | 84 | 0.660 |
Why?
| | Dietary Approaches To Stop Hypertension | 1 | 2020 | 13 | 0.650 |
Why?
| | Breath Tests | 2 | 2017 | 87 | 0.630 |
Why?
| | Food | 2 | 2020 | 159 | 0.630 |
Why?
| | Cardiovascular Diseases | 4 | 2024 | 2113 | 0.620 |
Why?
| | Phosphopeptides | 1 | 2018 | 20 | 0.600 |
Why?
| | Organic Chemicals | 1 | 2020 | 127 | 0.590 |
Why?
| | Peptide Mapping | 1 | 2018 | 64 | 0.590 |
Why?
| | Databases, Chemical | 1 | 2018 | 9 | 0.590 |
Why?
| | Eicosapentaenoic Acid | 3 | 2024 | 39 | 0.580 |
Why?
| | Monocytes | 1 | 2021 | 568 | 0.570 |
Why?
| | Tyrosine | 1 | 2018 | 224 | 0.560 |
Why?
| | Isotope Labeling | 1 | 2018 | 80 | 0.560 |
Why?
| | Hypersensitivity | 4 | 2022 | 256 | 0.530 |
Why?
| | Pulmonary Emphysema | 4 | 2019 | 290 | 0.530 |
Why?
| | Gastrointestinal Microbiome | 1 | 2025 | 696 | 0.530 |
Why?
| | Skin | 3 | 2018 | 751 | 0.520 |
Why?
| | Humans | 75 | 2025 | 137514 | 0.510 |
Why?
| | Plasma | 2 | 2017 | 213 | 0.510 |
Why?
| | Adaptor Proteins, Signal Transducing | 3 | 2018 | 429 | 0.510 |
Why?
| | Tobacco Smoke Pollution | 2 | 2017 | 284 | 0.510 |
Why?
| | Smoking | 7 | 2020 | 1639 | 0.500 |
Why?
| | Macrophages | 2 | 2021 | 1548 | 0.490 |
Why?
| | Mice, Inbred C57BL | 14 | 2025 | 5792 | 0.490 |
Why?
| | Gas Chromatography-Mass Spectrometry | 2 | 2020 | 134 | 0.480 |
Why?
| | Saliva | 1 | 2017 | 242 | 0.470 |
Why?
| | Glycerophospholipids | 4 | 2022 | 34 | 0.470 |
Why?
| | Dietary Supplements | 7 | 2025 | 563 | 0.470 |
Why?
| | Computational Biology | 3 | 2020 | 645 | 0.450 |
Why?
| | Salmon | 2 | 2025 | 22 | 0.450 |
Why?
| | Seafood | 2 | 2025 | 28 | 0.450 |
Why?
| | Nerve Tissue Proteins | 1 | 2018 | 599 | 0.450 |
Why?
| | Peptides | 4 | 2019 | 986 | 0.440 |
Why?
| | Leukotriene E4 | 3 | 2013 | 27 | 0.440 |
Why?
| | Alveolar Epithelial Cells | 3 | 2019 | 114 | 0.430 |
Why?
| | Mitochondria | 5 | 2023 | 947 | 0.430 |
Why?
| | Cell Differentiation | 2 | 2021 | 1979 | 0.420 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 2 | 2020 | 180 | 0.410 |
Why?
| | Chromatography, Reverse-Phase | 1 | 2013 | 28 | 0.410 |
Why?
| | Microbiota | 4 | 2022 | 763 | 0.390 |
Why?
| | Bronchoalveolar Lavage | 3 | 2018 | 93 | 0.390 |
Why?
| | Cholesterol | 3 | 2024 | 413 | 0.380 |
Why?
| | Endocannabinoids | 2 | 2022 | 63 | 0.370 |
Why?
| | Vitamins | 2 | 2025 | 176 | 0.370 |
Why?
| | Software | 4 | 2020 | 670 | 0.370 |
Why?
| | Sirtuin 3 | 3 | 2023 | 61 | 0.370 |
Why?
| | Autoantigens | 4 | 2019 | 429 | 0.370 |
Why?
| | Male | 45 | 2025 | 67718 | 0.370 |
Why?
| | Liver | 4 | 2020 | 1940 | 0.350 |
Why?
| | Reproducibility of Results | 7 | 2020 | 3292 | 0.340 |
Why?
| | Fatty Acids, Omega-3 | 2 | 2022 | 139 | 0.330 |
Why?
| | Sleep Deprivation | 2 | 2023 | 174 | 0.330 |
Why?
| | Transcriptome | 4 | 2022 | 974 | 0.320 |
Why?
| | Immunoenzyme Techniques | 1 | 2009 | 219 | 0.310 |
Why?
| | Species Specificity | 2 | 2020 | 593 | 0.300 |
Why?
| | Analgesia | 1 | 2010 | 110 | 0.300 |
Why?
| | Kainic Acid | 2 | 2018 | 35 | 0.280 |
Why?
| | Workflow | 2 | 2020 | 165 | 0.280 |
Why?
| | Minerals | 2 | 2025 | 42 | 0.280 |
Why?
| | Diet | 4 | 2024 | 1273 | 0.270 |
Why?
| | Sensitivity and Specificity | 5 | 2017 | 1950 | 0.270 |
Why?
| | Urinalysis | 2 | 2020 | 77 | 0.270 |
Why?
| | Interleukin-13 | 3 | 2024 | 149 | 0.270 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2025 | 544 | 0.270 |
Why?
| | Female | 38 | 2025 | 73162 | 0.270 |
Why?
| | Chromatography, Ion Exchange | 1 | 2007 | 54 | 0.270 |
Why?
| | Middle Aged | 20 | 2025 | 33355 | 0.260 |
Why?
| | Obesity | 7 | 2024 | 2974 | 0.260 |
Why?
| | Inflammation Mediators | 2 | 2020 | 514 | 0.260 |
Why?
| | Mitochondrial Proteins | 2 | 2019 | 257 | 0.260 |
Why?
| | Disease Models, Animal | 9 | 2025 | 4295 | 0.260 |
Why?
| | Blood Pressure | 4 | 2020 | 1776 | 0.250 |
Why?
| | Mucus | 2 | 2024 | 79 | 0.250 |
Why?
| | Data Interpretation, Statistical | 2 | 2018 | 352 | 0.250 |
Why?
| | Receptors, Lipoxin | 1 | 2025 | 3 | 0.250 |
Why?
| | Receptors, Formyl Peptide | 1 | 2025 | 7 | 0.250 |
Why?
| | Pulmonary Medicine | 1 | 2006 | 85 | 0.240 |
Why?
| | Diet, High-Fat | 3 | 2022 | 248 | 0.240 |
Why?
| | Body Fluids | 2 | 2017 | 66 | 0.240 |
Why?
| | Food Analysis | 1 | 2025 | 26 | 0.240 |
Why?
| | Sodium Nitrite | 2 | 2015 | 39 | 0.240 |
Why?
| | Dermatitis, Atopic | 3 | 2018 | 328 | 0.240 |
Why?
| | Fish Products | 1 | 2025 | 7 | 0.240 |
Why?
| | Receptors, G-Protein-Coupled | 3 | 2021 | 222 | 0.240 |
Why?
| | Fetal Growth Retardation | 2 | 2021 | 565 | 0.230 |
Why?
| | Germ-Free Life | 1 | 2025 | 34 | 0.230 |
Why?
| | Metals, Heavy | 1 | 2025 | 32 | 0.230 |
Why?
| | Cell Line | 7 | 2024 | 2852 | 0.230 |
Why?
| | Sleep | 4 | 2023 | 754 | 0.220 |
Why?
| | Flavoproteins | 1 | 2004 | 8 | 0.220 |
Why?
| | Photoreceptor Cells, Invertebrate | 1 | 2004 | 4 | 0.220 |
Why?
| | Chlamydomonas reinhardtii | 1 | 2004 | 8 | 0.220 |
Why?
| | Ethanol | 2 | 2019 | 608 | 0.220 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2016 | 1092 | 0.220 |
Why?
| | Membrane Microdomains | 1 | 2024 | 33 | 0.220 |
Why?
| | Fatty Acids, Unsaturated | 2 | 2022 | 98 | 0.220 |
Why?
| | Pilot Projects | 6 | 2022 | 1703 | 0.220 |
Why?
| | Agaricus | 1 | 2023 | 3 | 0.220 |
Why?
| | Lectins | 1 | 2024 | 49 | 0.220 |
Why?
| | GPI-Linked Proteins | 1 | 2024 | 71 | 0.220 |
Why?
| | Solid Phase Extraction | 2 | 2014 | 25 | 0.220 |
Why?
| | Mucin 5AC | 1 | 2024 | 70 | 0.210 |
Why?
| | Feces | 2 | 2025 | 479 | 0.210 |
Why?
| | Islet Amyloid Polypeptide | 2 | 2016 | 46 | 0.210 |
Why?
| | Eye Proteins | 1 | 2004 | 92 | 0.210 |
Why?
| | Mice, Knockout | 10 | 2025 | 3020 | 0.210 |
Why?
| | Oxadiazoles | 1 | 2003 | 35 | 0.210 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2020 | 144 | 0.210 |
Why?
| | Proteins | 3 | 2017 | 1012 | 0.210 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2003 | 59 | 0.210 |
Why?
| | Isoxazoles | 1 | 2003 | 54 | 0.210 |
Why?
| | Rhinovirus | 1 | 2003 | 57 | 0.210 |
Why?
| | Capsid | 1 | 2003 | 93 | 0.200 |
Why?
| | Plant Extracts | 1 | 2025 | 203 | 0.200 |
Why?
| | Arachidonic Acids | 1 | 2022 | 62 | 0.200 |
Why?
| | Acylation | 2 | 2019 | 30 | 0.190 |
Why?
| | Prostaglandins | 2 | 2022 | 97 | 0.190 |
Why?
| | Acute Lung Injury | 1 | 2025 | 288 | 0.190 |
Why?
| | Drosophila Proteins | 1 | 2004 | 202 | 0.190 |
Why?
| | Oxidative Stress | 4 | 2021 | 1307 | 0.190 |
Why?
| | Lipoxins | 1 | 2021 | 10 | 0.190 |
Why?
| | Cells, Cultured | 6 | 2021 | 4206 | 0.190 |
Why?
| | Myocardium | 3 | 2019 | 1004 | 0.190 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 2 | 2020 | 32 | 0.190 |
Why?
| | Linear Models | 2 | 2018 | 851 | 0.190 |
Why?
| | Hippocampus | 2 | 2018 | 903 | 0.190 |
Why?
| | Citrate (si)-Synthase | 1 | 2021 | 60 | 0.190 |
Why?
| | Bacterial Toxins | 1 | 2022 | 105 | 0.180 |
Why?
| | Liver Diseases, Alcoholic | 2 | 2019 | 95 | 0.180 |
Why?
| | Dinoprostone | 1 | 2022 | 191 | 0.180 |
Why?
| | Orthomyxoviridae Infections | 2 | 2024 | 75 | 0.180 |
Why?
| | Insulin-Secreting Cells | 3 | 2020 | 372 | 0.180 |
Why?
| | Brain Chemistry | 1 | 2021 | 120 | 0.180 |
Why?
| | Calcifediol | 2 | 2022 | 33 | 0.180 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2022 | 152 | 0.180 |
Why?
| | Quantitative Trait Loci | 2 | 2021 | 381 | 0.180 |
Why?
| | tat Gene Products, Human Immunodeficiency Virus | 1 | 2021 | 24 | 0.180 |
Why?
| | Receptors, Scavenger | 1 | 2021 | 25 | 0.180 |
Why?
| | Sepsis | 1 | 2007 | 611 | 0.180 |
Why?
| | Amidohydrolases | 1 | 2021 | 31 | 0.180 |
Why?
| | Sleep Disorders, Circadian Rhythm | 1 | 2021 | 50 | 0.170 |
Why?
| | Neuroprotection | 1 | 2021 | 42 | 0.170 |
Why?
| | Macrophages, Alveolar | 1 | 2024 | 392 | 0.170 |
Why?
| | Lipid Metabolism | 3 | 2018 | 511 | 0.170 |
Why?
| | Phosphatidylinositol 4,5-Diphosphate | 1 | 2020 | 32 | 0.170 |
Why?
| | Vitamin D Deficiency | 1 | 2022 | 183 | 0.170 |
Why?
| | Leukocytes, Mononuclear | 4 | 2022 | 558 | 0.170 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2020 | 47 | 0.170 |
Why?
| | Oxylipins | 3 | 2025 | 40 | 0.170 |
Why?
| | Nasal Polyps | 1 | 2020 | 59 | 0.170 |
Why?
| | Melatonin | 1 | 2021 | 152 | 0.170 |
Why?
| | Vital Capacity | 2 | 2018 | 309 | 0.160 |
Why?
| | Vesicular Transport Proteins | 1 | 2020 | 84 | 0.160 |
Why?
| | Biotransformation | 1 | 2020 | 68 | 0.160 |
Why?
| | Phosphorylation | 4 | 2019 | 1762 | 0.160 |
Why?
| | Neuroprotective Agents | 1 | 2021 | 132 | 0.160 |
Why?
| | Phosphatidylcholines | 1 | 2020 | 148 | 0.160 |
Why?
| | Anti-Citrullinated Protein Antibodies | 1 | 2021 | 115 | 0.160 |
Why?
| | Protein Deglycase DJ-1 | 1 | 2019 | 11 | 0.160 |
Why?
| | Succinic Acid | 1 | 2019 | 40 | 0.160 |
Why?
| | Myofibrils | 1 | 2019 | 49 | 0.160 |
Why?
| | Umbilical Arteries | 1 | 2020 | 54 | 0.160 |
Why?
| | Lung Injury | 1 | 2022 | 218 | 0.160 |
Why?
| | Cross-Over Studies | 2 | 2020 | 561 | 0.160 |
Why?
| | Tubulin | 1 | 2020 | 141 | 0.160 |
Why?
| | Anthracenes | 1 | 2019 | 31 | 0.160 |
Why?
| | Bariatric Surgery | 1 | 2022 | 216 | 0.160 |
Why?
| | Hyperinsulinism | 1 | 2020 | 121 | 0.160 |
Why?
| | Insulin | 3 | 2022 | 2398 | 0.160 |
Why?
| | Epithelium | 1 | 2020 | 315 | 0.160 |
Why?
| | Islets of Langerhans | 2 | 2019 | 803 | 0.150 |
Why?
| | Uterine Artery | 1 | 2020 | 79 | 0.150 |
Why?
| | Aging | 3 | 2023 | 1866 | 0.150 |
Why?
| | Liposomes | 1 | 2020 | 221 | 0.150 |
Why?
| | Rhinitis | 1 | 2020 | 158 | 0.150 |
Why?
| | DNA End-Joining Repair | 1 | 2019 | 20 | 0.150 |
Why?
| | Fluorenes | 1 | 2019 | 42 | 0.150 |
Why?
| | Neurodegenerative Diseases | 1 | 2021 | 137 | 0.150 |
Why?
| | Aged | 11 | 2023 | 23798 | 0.150 |
Why?
| | Inhalation Exposure | 2 | 2021 | 107 | 0.150 |
Why?
| | Dietary Proteins | 1 | 2020 | 135 | 0.150 |
Why?
| | Trypsin | 1 | 2018 | 77 | 0.150 |
Why?
| | Synapses | 1 | 2022 | 426 | 0.150 |
Why?
| | Spleen | 1 | 2020 | 516 | 0.150 |
Why?
| | Excitatory Amino Acid Agonists | 1 | 2018 | 39 | 0.150 |
Why?
| | C-Peptide | 2 | 2016 | 163 | 0.150 |
Why?
| | Adult | 15 | 2025 | 37821 | 0.150 |
Why?
| | B-Lymphocyte Subsets | 1 | 2018 | 75 | 0.150 |
Why?
| | Leukotrienes | 1 | 2018 | 37 | 0.150 |
Why?
| | Gene Expression | 4 | 2020 | 1505 | 0.140 |
Why?
| | Microtubules | 1 | 2020 | 270 | 0.140 |
Why?
| | Cysteine | 1 | 2019 | 206 | 0.140 |
Why?
| | Myocardial Ischemia | 1 | 2019 | 263 | 0.140 |
Why?
| | Sinusitis | 1 | 2020 | 221 | 0.140 |
Why?
| | Bacteria | 1 | 2025 | 858 | 0.140 |
Why?
| | Epilepsy, Temporal Lobe | 1 | 2018 | 38 | 0.140 |
Why?
| | Diet, Ketogenic | 1 | 2018 | 37 | 0.140 |
Why?
| | Limit of Detection | 1 | 2018 | 86 | 0.140 |
Why?
| | NAD | 1 | 2018 | 77 | 0.140 |
Why?
| | Flow Injection Analysis | 1 | 2017 | 5 | 0.140 |
Why?
| | Niacinamide | 1 | 2018 | 79 | 0.140 |
Why?
| | Fatty Acids, Essential | 1 | 2017 | 3 | 0.140 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 309 | 0.140 |
Why?
| | Inflammasomes | 1 | 2018 | 128 | 0.140 |
Why?
| | Kynurenine | 1 | 2018 | 114 | 0.140 |
Why?
| | Sample Size | 1 | 2017 | 118 | 0.130 |
Why?
| | Adiponectin | 2 | 2022 | 241 | 0.130 |
Why?
| | Health | 1 | 2017 | 84 | 0.130 |
Why?
| | Hydrolases | 1 | 2017 | 56 | 0.130 |
Why?
| | Interleukin-6 | 2 | 2021 | 778 | 0.130 |
Why?
| | Nerve Growth Factors | 1 | 2017 | 80 | 0.130 |
Why?
| | Antibodies | 1 | 2018 | 414 | 0.130 |
Why?
| | Autoimmunity | 2 | 2021 | 907 | 0.130 |
Why?
| | Immunophenotyping | 2 | 2018 | 321 | 0.130 |
Why?
| | Proline | 1 | 2017 | 80 | 0.130 |
Why?
| | Disease | 1 | 2017 | 98 | 0.130 |
Why?
| | Sphingolipids | 1 | 2017 | 77 | 0.130 |
Why?
| | Hyperglycemia | 1 | 2020 | 346 | 0.130 |
Why?
| | Artifacts | 1 | 2017 | 137 | 0.130 |
Why?
| | Influenza, Human | 1 | 2022 | 632 | 0.130 |
Why?
| | Actins | 1 | 2018 | 416 | 0.130 |
Why?
| | Immunity, Humoral | 1 | 2017 | 118 | 0.130 |
Why?
| | Sex Characteristics | 1 | 2021 | 766 | 0.130 |
Why?
| | High-Throughput Screening Assays | 1 | 2017 | 159 | 0.120 |
Why?
| | Epitopes | 2 | 2016 | 481 | 0.120 |
Why?
| | Emphysema | 2 | 2013 | 109 | 0.120 |
Why?
| | Acetylation | 3 | 2023 | 254 | 0.120 |
Why?
| | Cardiomyopathies | 1 | 2019 | 350 | 0.120 |
Why?
| | HEK293 Cells | 1 | 2018 | 734 | 0.120 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 3 | 2011 | 114 | 0.120 |
Why?
| | Signal Transduction | 4 | 2022 | 5096 | 0.120 |
Why?
| | Vascular Stiffness | 2 | 2018 | 492 | 0.120 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2016 | 187 | 0.120 |
Why?
| | Arginine | 1 | 2017 | 274 | 0.120 |
Why?
| | Cytokines | 4 | 2025 | 2095 | 0.120 |
Why?
| | Apoptosis | 4 | 2017 | 2557 | 0.120 |
Why?
| | Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2015 | 38 | 0.120 |
Why?
| | Glycosphingolipids | 1 | 2015 | 7 | 0.120 |
Why?
| | Amino Acid Sequence | 5 | 2016 | 2146 | 0.120 |
Why?
| | Aorta | 2 | 2015 | 421 | 0.120 |
Why?
| | Electrophysiology | 1 | 2015 | 221 | 0.120 |
Why?
| | Respiratory Mucosa | 2 | 2024 | 324 | 0.120 |
Why?
| | Metabolic Syndrome | 1 | 2018 | 354 | 0.120 |
Why?
| | Forensic Sciences | 1 | 2014 | 6 | 0.120 |
Why?
| | Endoplasmic Reticulum | 1 | 2017 | 265 | 0.110 |
Why?
| | Chlorine | 1 | 2015 | 61 | 0.110 |
Why?
| | Brain | 2 | 2018 | 2831 | 0.110 |
Why?
| | Patch-Clamp Techniques | 1 | 2015 | 288 | 0.110 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2016 | 194 | 0.110 |
Why?
| | Carotid Arteries | 1 | 2015 | 206 | 0.110 |
Why?
| | Interleukin-16 | 1 | 2013 | 6 | 0.110 |
Why?
| | Insulin Resistance | 1 | 2022 | 1198 | 0.110 |
Why?
| | Cerebrospinal Fluid | 1 | 2014 | 94 | 0.110 |
Why?
| | Lipopolysaccharides | 2 | 2025 | 886 | 0.110 |
Why?
| | Leukotriene Antagonists | 1 | 2013 | 43 | 0.110 |
Why?
| | Gangliosides | 1 | 2013 | 20 | 0.110 |
Why?
| | Cholesterol Side-Chain Cleavage Enzyme | 1 | 2013 | 9 | 0.100 |
Why?
| | Lung Diseases | 2 | 2013 | 768 | 0.100 |
Why?
| | Methyl Ethers | 1 | 2013 | 13 | 0.100 |
Why?
| | Up-Regulation | 2 | 2019 | 846 | 0.100 |
Why?
| | Diabetes Mellitus, Type 1 | 4 | 2019 | 3708 | 0.100 |
Why?
| | Education | 1 | 2013 | 108 | 0.100 |
Why?
| | Health Status | 1 | 2018 | 784 | 0.100 |
Why?
| | Methanol | 1 | 2013 | 38 | 0.100 |
Why?
| | Smoking Cessation | 1 | 2017 | 447 | 0.100 |
Why?
| | Adrenergic beta-Agonists | 1 | 2013 | 133 | 0.100 |
Why?
| | Case-Control Studies | 2 | 2018 | 3546 | 0.100 |
Why?
| | Nasal Mucosa | 2 | 2024 | 109 | 0.100 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2013 | 191 | 0.100 |
Why?
| | Alcohol Drinking | 1 | 2019 | 824 | 0.100 |
Why?
| | Epilepsy | 1 | 2016 | 334 | 0.100 |
Why?
| | Arthritis, Rheumatoid | 1 | 2021 | 1163 | 0.090 |
Why?
| | Hydroxyeicosatetraenoic Acids | 2 | 2022 | 43 | 0.090 |
Why?
| | Bronchodilator Agents | 1 | 2013 | 248 | 0.090 |
Why?
| | Mice, Inbred NOD | 4 | 2016 | 601 | 0.090 |
Why?
| | Muscle, Skeletal | 1 | 2021 | 1701 | 0.090 |
Why?
| | B-Lymphocytes | 1 | 2017 | 847 | 0.090 |
Why?
| | Heart Diseases | 1 | 2015 | 359 | 0.090 |
Why?
| | Oxidation-Reduction | 3 | 2020 | 1059 | 0.090 |
Why?
| | Molecular Sequence Data | 4 | 2016 | 2901 | 0.090 |
Why?
| | Fatty Acids | 3 | 2018 | 445 | 0.090 |
Why?
| | Ovarian Follicle | 1 | 2011 | 71 | 0.090 |
Why?
| | Kaposi Varicelliform Eruption | 1 | 2011 | 21 | 0.090 |
Why?
| | fas Receptor | 1 | 2011 | 95 | 0.090 |
Why?
| | Calcium | 1 | 2017 | 1233 | 0.090 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2013 | 340 | 0.090 |
Why?
| | Aged, 80 and over | 3 | 2018 | 7593 | 0.090 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 2018 | 346 | 0.090 |
Why?
| | Pregnancy | 5 | 2025 | 6745 | 0.090 |
Why?
| | Motor Activity | 1 | 2015 | 723 | 0.090 |
Why?
| | Aluminum | 1 | 2010 | 42 | 0.080 |
Why?
| | Mice, Obese | 2 | 2021 | 66 | 0.080 |
Why?
| | Dietary Fats | 2 | 2022 | 301 | 0.080 |
Why?
| | Pneumonia, Mycoplasma | 1 | 2010 | 56 | 0.080 |
Why?
| | Rats | 4 | 2022 | 5676 | 0.080 |
Why?
| | Toll-Like Receptor 2 | 1 | 2010 | 117 | 0.080 |
Why?
| | Sarcomeres | 1 | 2010 | 95 | 0.080 |
Why?
| | E2F2 Transcription Factor | 1 | 2009 | 15 | 0.080 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2009 | 26 | 0.080 |
Why?
| | Light | 2 | 2021 | 383 | 0.080 |
Why?
| | Chromogranin A | 1 | 2010 | 42 | 0.080 |
Why?
| | Ovary | 1 | 2011 | 218 | 0.080 |
Why?
| | Gene Expression Regulation | 3 | 2015 | 2615 | 0.080 |
Why?
| | Anti-Asthmatic Agents | 1 | 2013 | 393 | 0.080 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2009 | 71 | 0.080 |
Why?
| | Lymphocyte Activation | 3 | 2018 | 1150 | 0.080 |
Why?
| | Adjuvants, Immunologic | 1 | 2010 | 226 | 0.080 |
Why?
| | Endothelium, Vascular | 1 | 2015 | 923 | 0.080 |
Why?
| | Protein C | 1 | 2009 | 59 | 0.080 |
Why?
| | Binding Sites | 2 | 2020 | 1310 | 0.080 |
Why?
| | Glycoproteins | 1 | 2010 | 345 | 0.070 |
Why?
| | Muscle Proteins | 1 | 2010 | 229 | 0.070 |
Why?
| | Sphingomyelins | 2 | 2020 | 33 | 0.070 |
Why?
| | Sirtuins | 2 | 2019 | 42 | 0.070 |
Why?
| | Group IV Phospholipases A2 | 2 | 2019 | 47 | 0.070 |
Why?
| | Phosphoproteins | 1 | 2010 | 338 | 0.070 |
Why?
| | Vasoconstriction | 1 | 2009 | 202 | 0.070 |
Why?
| | Reactive Oxygen Species | 2 | 2023 | 619 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2022 | 2521 | 0.070 |
Why?
| | Interleukin-1beta | 2 | 2021 | 373 | 0.070 |
Why?
| | Glucose | 2 | 2023 | 1018 | 0.070 |
Why?
| | Inflammation | 3 | 2024 | 2837 | 0.070 |
Why?
| | Cognition | 1 | 2015 | 1192 | 0.070 |
Why?
| | Diet, Western | 2 | 2018 | 81 | 0.070 |
Why?
| | Transcriptional Activation | 1 | 2009 | 379 | 0.070 |
Why?
| | Pulmonary Fibrosis | 1 | 2011 | 400 | 0.070 |
Why?
| | Rats, Sprague-Dawley | 3 | 2018 | 2501 | 0.070 |
Why?
| | Child | 6 | 2024 | 22037 | 0.070 |
Why?
| | Biomedical Research | 1 | 2013 | 689 | 0.070 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2021 | 2193 | 0.070 |
Why?
| | Curriculum | 1 | 2013 | 980 | 0.070 |
Why?
| | Disease Susceptibility | 2 | 2019 | 344 | 0.070 |
Why?
| | Exercise | 1 | 2018 | 2024 | 0.070 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2013 | 917 | 0.070 |
Why?
| | Phenotype | 4 | 2018 | 3205 | 0.070 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2008 | 368 | 0.060 |
Why?
| | Pulmonary Alveoli | 1 | 2009 | 405 | 0.060 |
Why?
| | Heart Failure | 1 | 2019 | 2222 | 0.060 |
Why?
| | Staphylococcal Infections | 1 | 2011 | 402 | 0.060 |
Why?
| | Fibroblasts | 1 | 2011 | 990 | 0.060 |
Why?
| | Peptide Fragments | 1 | 2010 | 708 | 0.060 |
Why?
| | Xanthophylls | 1 | 2025 | 18 | 0.060 |
Why?
| | Isomerism | 1 | 2025 | 56 | 0.060 |
Why?
| | Iodine | 1 | 2025 | 27 | 0.060 |
Why?
| | Food Handling | 1 | 2025 | 60 | 0.060 |
Why?
| | Mice, Inbred BALB C | 2 | 2019 | 1271 | 0.060 |
Why?
| | Algal Proteins | 1 | 2004 | 6 | 0.060 |
Why?
| | Cysteine Endopeptidases | 1 | 2004 | 72 | 0.050 |
Why?
| | Multienzyme Complexes | 1 | 2004 | 69 | 0.050 |
Why?
| | Choline | 1 | 2025 | 131 | 0.050 |
Why?
| | Cryptochromes | 1 | 2004 | 25 | 0.050 |
Why?
| | Gene Deletion | 1 | 2025 | 393 | 0.050 |
Why?
| | Antigen-Antibody Reactions | 1 | 2003 | 55 | 0.050 |
Why?
| | Oxazoles | 1 | 2003 | 37 | 0.050 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 2 | 2019 | 283 | 0.050 |
Why?
| | Protoplasts | 1 | 2003 | 7 | 0.050 |
Why?
| | Protein Binding | 2 | 2020 | 2229 | 0.050 |
Why?
| | Quality Control | 1 | 2023 | 171 | 0.050 |
Why?
| | Down-Regulation | 2 | 2020 | 658 | 0.050 |
Why?
| | RNA, Small Interfering | 2 | 2018 | 621 | 0.050 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2004 | 156 | 0.050 |
Why?
| | Microscopy, Electron | 1 | 2003 | 434 | 0.050 |
Why?
| | Cannabinoid Receptor Modulators | 1 | 2022 | 8 | 0.050 |
Why?
| | Polyunsaturated Alkamides | 1 | 2022 | 8 | 0.050 |
Why?
| | Cholesterol, HDL | 1 | 2023 | 205 | 0.050 |
Why?
| | Introns | 1 | 2004 | 256 | 0.050 |
Why?
| | Receptors, Cannabinoid | 1 | 2022 | 15 | 0.050 |
Why?
| | Young Adult | 5 | 2020 | 13243 | 0.050 |
Why?
| | Enzyme Activation | 2 | 2019 | 816 | 0.050 |
Why?
| | Virus Assembly | 1 | 2003 | 77 | 0.050 |
Why?
| | Exons | 1 | 2004 | 349 | 0.050 |
Why?
| | National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2022 | 21 | 0.050 |
Why?
| | Recombinant Proteins | 2 | 2020 | 1357 | 0.050 |
Why?
| | Patient Acuity | 1 | 2022 | 47 | 0.050 |
Why?
| | Seeds | 1 | 2003 | 86 | 0.050 |
Why?
| | Receptor, Cannabinoid, CB1 | 1 | 2022 | 45 | 0.050 |
Why?
| | Epithelial Cells | 2 | 2024 | 1099 | 0.050 |
Why?
| | Cholecalciferol | 1 | 2022 | 58 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2004 | 403 | 0.050 |
Why?
| | Mutation | 2 | 2004 | 3964 | 0.050 |
Why?
| | Diet, Carbohydrate-Restricted | 1 | 2022 | 37 | 0.050 |
Why?
| | Cell Line, Tumor | 2 | 2020 | 3420 | 0.050 |
Why?
| | Double-Blind Method | 2 | 2018 | 1987 | 0.050 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2022 | 130 | 0.050 |
Why?
| | HeLa Cells | 1 | 2003 | 640 | 0.050 |
Why?
| | Membrane Proteins | 1 | 2008 | 1167 | 0.050 |
Why?
| | Immunity | 1 | 2022 | 145 | 0.050 |
Why?
| | Dietary Carbohydrates | 1 | 2022 | 153 | 0.050 |
Why?
| | Cattle | 1 | 2024 | 982 | 0.040 |
Why?
| | Protein Conformation, beta-Strand | 1 | 2020 | 17 | 0.040 |
Why?
| | 3T3-L1 Cells | 1 | 2020 | 35 | 0.040 |
Why?
| | Adolescent | 4 | 2020 | 21555 | 0.040 |
Why?
| | Polymorphism, Genetic | 1 | 2024 | 658 | 0.040 |
Why?
| | Leptin | 1 | 2022 | 233 | 0.040 |
Why?
| | Adenosine | 1 | 2022 | 227 | 0.040 |
Why?
| | Oxidative Phosphorylation | 1 | 2021 | 193 | 0.040 |
Why?
| | Sirtuin 2 | 1 | 2020 | 25 | 0.040 |
Why?
| | Phosphatidylinositols | 1 | 2020 | 57 | 0.040 |
Why?
| | Prescriptions | 1 | 2021 | 67 | 0.040 |
Why?
| | Glutamic Acid | 1 | 2022 | 249 | 0.040 |
Why?
| | Phosphatidylethanolamines | 1 | 2020 | 77 | 0.040 |
Why?
| | Longitudinal Studies | 2 | 2022 | 2857 | 0.040 |
Why?
| | Phosphatidylserines | 1 | 2020 | 91 | 0.040 |
Why?
| | Receptors, Chemokine | 1 | 2020 | 47 | 0.040 |
Why?
| | Placental Insufficiency | 1 | 2021 | 116 | 0.040 |
Why?
| | Molecular Docking Simulation | 1 | 2020 | 117 | 0.040 |
Why?
| | Metaplasia | 1 | 2020 | 60 | 0.040 |
Why?
| | Neurons | 2 | 2023 | 1613 | 0.040 |
Why?
| | Adipose Tissue, White | 1 | 2020 | 40 | 0.040 |
Why?
| | Sex Factors | 2 | 2018 | 2074 | 0.040 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2021 | 216 | 0.040 |
Why?
| | Synaptic Transmission | 1 | 2022 | 291 | 0.040 |
Why?
| | Interleukin-8 | 1 | 2021 | 269 | 0.040 |
Why?
| | Triglycerides | 1 | 2022 | 525 | 0.040 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2020 | 54 | 0.040 |
Why?
| | Calcium Signaling | 2 | 2015 | 253 | 0.040 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2020 | 151 | 0.040 |
Why?
| | Lipid Bilayers | 1 | 2020 | 101 | 0.040 |
Why?
| | Cohort Studies | 2 | 2021 | 5730 | 0.040 |
Why?
| | Neutrophils | 1 | 2025 | 1238 | 0.040 |
Why?
| | Cloning, Molecular | 1 | 2020 | 536 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2020 | 108 | 0.040 |
Why?
| | Nutritional Sciences | 1 | 2020 | 42 | 0.040 |
Why?
| | Water | 1 | 2003 | 464 | 0.040 |
Why?
| | Pregnancy Trimester, Third | 1 | 2020 | 113 | 0.040 |
Why?
| | Cellular Reprogramming | 1 | 2020 | 98 | 0.040 |
Why?
| | Ultrasonography, Doppler | 1 | 2020 | 123 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 2 | 2021 | 2420 | 0.040 |
Why?
| | Infant, Small for Gestational Age | 1 | 2020 | 92 | 0.040 |
Why?
| | Genetic Vectors | 1 | 2020 | 322 | 0.040 |
Why?
| | Antibodies, Viral | 1 | 2003 | 623 | 0.040 |
Why?
| | Piperidines | 1 | 2021 | 208 | 0.040 |
Why?
| | Vitamin D | 1 | 2022 | 393 | 0.040 |
Why?
| | Crystallography, X-Ray | 1 | 2020 | 474 | 0.040 |
Why?
| | Methylation | 1 | 2019 | 237 | 0.040 |
Why?
| | Biological Transport | 1 | 2020 | 416 | 0.040 |
Why?
| | Adaptation, Physiological | 1 | 2003 | 546 | 0.040 |
Why?
| | Fibrinogen | 2 | 2010 | 170 | 0.040 |
Why?
| | Sheep | 1 | 2021 | 855 | 0.040 |
Why?
| | Glucose Intolerance | 1 | 2020 | 146 | 0.040 |
Why?
| | Citric Acid Cycle | 1 | 2018 | 59 | 0.040 |
Why?
| | Molecular Weight | 1 | 2019 | 332 | 0.040 |
Why?
| | Interferons | 1 | 2020 | 199 | 0.040 |
Why?
| | Molecular Dynamics Simulation | 1 | 2020 | 238 | 0.040 |
Why?
| | Cilia | 1 | 2020 | 186 | 0.040 |
Why?
| | Lymphocyte Count | 1 | 2018 | 150 | 0.040 |
Why?
| | Animals, Newborn | 1 | 2021 | 845 | 0.040 |
Why?
| | Germinal Center | 1 | 2018 | 58 | 0.040 |
Why?
| | Microglia | 1 | 2021 | 251 | 0.040 |
Why?
| | Cyclooxygenase 2 | 1 | 2019 | 178 | 0.040 |
Why?
| | Metagenomics | 1 | 2020 | 167 | 0.040 |
Why?
| | GTP Phosphohydrolases | 1 | 2018 | 91 | 0.040 |
Why?
| | Caspase 1 | 1 | 2018 | 143 | 0.040 |
Why?
| | Native Polyacrylamide Gel Electrophoresis | 1 | 2018 | 3 | 0.040 |
Why?
| | Models, Molecular | 1 | 2003 | 1586 | 0.040 |
Why?
| | Naphthoquinones | 1 | 2018 | 19 | 0.040 |
Why?
| | Pyridinium Compounds | 1 | 2018 | 27 | 0.040 |
Why?
| | Fluorescent Antibody Technique | 1 | 2019 | 386 | 0.040 |
Why?
| | Ultrasonography, Prenatal | 1 | 2020 | 284 | 0.040 |
Why?
| | Predictive Value of Tests | 2 | 2015 | 2039 | 0.040 |
Why?
| | Methionine | 1 | 2018 | 159 | 0.040 |
Why?
| | Proportional Hazards Models | 1 | 2021 | 1263 | 0.040 |
Why?
| | Phospholipase A2 Inhibitors | 1 | 2017 | 3 | 0.040 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 1465 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2018 | 313 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2018 | 155 | 0.030 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 151 | 0.030 |
Why?
| | Lysine | 1 | 2019 | 297 | 0.030 |
Why?
| | Pregnancy Outcome | 1 | 2020 | 413 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2021 | 1524 | 0.030 |
Why?
| | Weight Loss | 1 | 2022 | 770 | 0.030 |
Why?
| | Energy Intake | 1 | 2020 | 478 | 0.030 |
Why?
| | Nutritional Status | 1 | 2020 | 344 | 0.030 |
Why?
| | Toll-Like Receptor 9 | 1 | 2017 | 32 | 0.030 |
Why?
| | Circadian Rhythm | 1 | 2021 | 463 | 0.030 |
Why?
| | Pyridines | 1 | 2021 | 508 | 0.030 |
Why?
| | Forensic Medicine | 1 | 2017 | 18 | 0.030 |
Why?
| | Transfection | 1 | 2019 | 948 | 0.030 |
Why?
| | Fetus | 1 | 2021 | 807 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2017 | 2838 | 0.030 |
Why?
| | Pyrrolidines | 1 | 2017 | 80 | 0.030 |
Why?
| | Catalytic Domain | 1 | 2018 | 227 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2018 | 329 | 0.030 |
Why?
| | Caloric Restriction | 1 | 2018 | 121 | 0.030 |
Why?
| | Gestational Age | 1 | 2020 | 903 | 0.030 |
Why?
| | Family | 1 | 2021 | 667 | 0.030 |
Why?
| | Tissue Donors | 1 | 2019 | 417 | 0.030 |
Why?
| | RNA-Binding Proteins | 2 | 2011 | 424 | 0.030 |
Why?
| | Escherichia coli | 1 | 2020 | 815 | 0.030 |
Why?
| | Influenza A virus | 1 | 2017 | 109 | 0.030 |
Why?
| | DNA Damage | 1 | 2019 | 420 | 0.030 |
Why?
| | Methemoglobin | 1 | 2015 | 21 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2017 | 586 | 0.030 |
Why?
| | Gene Regulatory Networks | 1 | 2018 | 308 | 0.030 |
Why?
| | Body Mass Index | 2 | 2015 | 2369 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2021 | 1242 | 0.030 |
Why?
| | Hydrogen Peroxide | 1 | 2017 | 320 | 0.030 |
Why?
| | Immunoglobulin M | 1 | 2017 | 288 | 0.030 |
Why?
| | Clone Cells | 1 | 2016 | 266 | 0.030 |
Why?
| | Etiocholanolone | 1 | 2015 | 6 | 0.030 |
Why?
| | Gerbillinae | 1 | 2015 | 66 | 0.030 |
Why?
| | Ranolazine | 1 | 2015 | 25 | 0.030 |
Why?
| | Trihexosylceramides | 1 | 2015 | 4 | 0.030 |
Why?
| | Thiocyanates | 1 | 2015 | 31 | 0.030 |
Why?
| | Severity of Illness Index | 2 | 2015 | 2838 | 0.030 |
Why?
| | Elasticity | 1 | 2015 | 195 | 0.030 |
Why?
| | Placenta | 1 | 2021 | 754 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2021 | 1436 | 0.030 |
Why?
| | Prospective Studies | 2 | 2021 | 7598 | 0.030 |
Why?
| | Pulse Wave Analysis | 1 | 2015 | 269 | 0.030 |
Why?
| | Genomics | 1 | 2020 | 793 | 0.030 |
Why?
| | Mitochondria, Heart | 1 | 2015 | 100 | 0.030 |
Why?
| | Child, Preschool | 1 | 2009 | 11097 | 0.030 |
Why?
| | Chronic Disease | 1 | 2020 | 1790 | 0.030 |
Why?
| | Cardiotonic Agents | 1 | 2015 | 126 | 0.030 |
Why?
| | Brachial Artery | 1 | 2015 | 200 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2020 | 832 | 0.030 |
Why?
| | Molecular Targeted Therapy | 1 | 2017 | 414 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2792 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2017 | 367 | 0.030 |
Why?
| | Salmeterol Xinafoate | 1 | 2013 | 41 | 0.030 |
Why?
| | Time Factors | 2 | 2019 | 6817 | 0.030 |
Why?
| | Cyclopropanes | 1 | 2013 | 90 | 0.030 |
Why?
| | Pregnenolone | 1 | 2013 | 3 | 0.030 |
Why?
| | Fluticasone | 1 | 2013 | 90 | 0.030 |
Why?
| | Immune Tolerance | 1 | 2016 | 362 | 0.030 |
Why?
| | Androstadienes | 1 | 2013 | 107 | 0.030 |
Why?
| | Disease Progression | 1 | 2021 | 2755 | 0.030 |
Why?
| | Albuterol | 1 | 2013 | 110 | 0.030 |
Why?
| | Acetates | 1 | 2013 | 100 | 0.030 |
Why?
| | Sulfides | 1 | 2013 | 99 | 0.020 |
Why?
| | Leukocyte Count | 1 | 2013 | 331 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2017 | 2066 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 2015 | 487 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2013 | 434 | 0.020 |
Why?
| | Colorado | 1 | 2022 | 4521 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 344 | 0.020 |
Why?
| | Interleukin-4 | 1 | 2013 | 217 | 0.020 |
Why?
| | Energy Metabolism | 1 | 2018 | 895 | 0.020 |
Why?
| | Quinolines | 1 | 2013 | 180 | 0.020 |
Why?
| | Vasodilation | 1 | 2015 | 494 | 0.020 |
Why?
| | Forced Expiratory Volume | 1 | 2013 | 532 | 0.020 |
Why?
| | Mesocricetus | 1 | 2011 | 39 | 0.020 |
Why?
| | Genetic Association Studies | 1 | 2013 | 377 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1800 | 0.020 |
Why?
| | Interleukin-2 | 1 | 2013 | 456 | 0.020 |
Why?
| | Fas Ligand Protein | 1 | 2011 | 59 | 0.020 |
Why?
| | Antioxidants | 1 | 2015 | 577 | 0.020 |
Why?
| | Cell Line, Transformed | 1 | 2011 | 145 | 0.020 |
Why?
| | Cricetinae | 1 | 2011 | 288 | 0.020 |
Why?
| | Antigen-Presenting Cells | 1 | 2011 | 156 | 0.020 |
Why?
| | Eosinophils | 1 | 2013 | 331 | 0.020 |
Why?
| | Regression Analysis | 1 | 2013 | 1029 | 0.020 |
Why?
| | Salts | 1 | 2010 | 37 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 849 | 0.020 |
Why?
| | Myocytes, Cardiac | 1 | 2015 | 528 | 0.020 |
Why?
| | Nitric Oxide | 1 | 2015 | 914 | 0.020 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2010 | 86 | 0.020 |
Why?
| | HLA-A Antigens | 1 | 2010 | 56 | 0.020 |
Why?
| | Fibrin | 1 | 2010 | 80 | 0.020 |
Why?
| | Surgical Tape | 1 | 2009 | 5 | 0.020 |
Why?
| | Endothelin-Converting Enzymes | 1 | 2009 | 10 | 0.020 |
Why?
| | Adrenal Cortex Hormones | 1 | 2013 | 555 | 0.020 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2009 | 29 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2013 | 790 | 0.020 |
Why?
| | Thrombin | 1 | 2010 | 152 | 0.020 |
Why?
| | Metalloendopeptidases | 1 | 2009 | 62 | 0.020 |
Why?
| | alpha-2-HS-Glycoprotein | 1 | 2009 | 2 | 0.020 |
Why?
| | Immunoglobulin J-Chains | 1 | 2009 | 6 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2011 | 683 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2010 | 225 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2020 | 5427 | 0.020 |
Why?
| | Pulmonary Surfactant-Associated Protein A | 1 | 2009 | 35 | 0.020 |
Why?
| | Haptoglobins | 1 | 2009 | 53 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2009 | 300 | 0.020 |
Why?
| | Albumins | 1 | 2009 | 114 | 0.020 |
Why?
| | Risk | 1 | 2011 | 905 | 0.020 |
Why?
| | Phosphotyrosine | 1 | 2008 | 38 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2020 | 6059 | 0.020 |
Why?
| | alpha 1-Antitrypsin | 1 | 2009 | 108 | 0.020 |
Why?
| | Endothelin-1 | 1 | 2009 | 181 | 0.020 |
Why?
| | Databases, Factual | 1 | 2013 | 1351 | 0.020 |
Why?
| | Drug Interactions | 1 | 2009 | 409 | 0.020 |
Why?
| | src-Family Kinases | 1 | 2008 | 94 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 170 | 0.020 |
Why?
| | Blood Proteins | 1 | 2009 | 250 | 0.020 |
Why?
| | Nanotechnology | 1 | 2008 | 126 | 0.020 |
Why?
| | Protein Conformation | 1 | 2010 | 930 | 0.020 |
Why?
| | Lymphoma | 1 | 2008 | 207 | 0.020 |
Why?
| | Staphylococcus aureus | 1 | 2011 | 452 | 0.020 |
Why?
| | Cell Cycle | 1 | 2009 | 604 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2011 | 856 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2008 | 437 | 0.020 |
Why?
| | Algorithms | 1 | 2013 | 1702 | 0.020 |
Why?
| | Age Factors | 1 | 2013 | 3301 | 0.020 |
Why?
| | Cell Membrane | 1 | 2009 | 751 | 0.020 |
Why?
| | United States | 1 | 2022 | 14696 | 0.010 |
Why?
| | Histones | 1 | 2010 | 641 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2009 | 1255 | 0.010 |
Why?
| | Immunoglobulin G | 1 | 2009 | 886 | 0.010 |
Why?
| | Pyrimidines | 1 | 2008 | 472 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2011 | 1770 | 0.010 |
Why?
| | Raffinose | 1 | 2003 | 24 | 0.010 |
Why?
| | Germination | 1 | 2003 | 6 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2681 | 0.010 |
Why?
| | Sucrose | 1 | 2003 | 109 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2010 | 1999 | 0.010 |
Why?
| | Vaccination | 1 | 2010 | 1398 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2008 | 1428 | 0.010 |
Why?
| | Risk Factors | 1 | 2015 | 10356 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2011 | 5772 | 0.010 |
Why?
|
|
Reisdorph's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|